PE Anti-Human CD196 (CCR6) Antibody
英诺赛图(InnoCyto)的 PE Anti-Human CD196 (CCR6) Antibody(克隆 196AM2b) 为鼠源 IgG2b 单克隆抗体,靶向 CD196(别名 CCR6 等),PE 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,559 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 PE Anti-Human CD196 (CCR6) Antibody(克隆 196AM2b) 为鼠源 IgG2b 单克隆抗体,靶向 CD196(别名 CCR6 等),PE 标记(488 nm 蓝色激光激发),适用于流式细胞术。提供 25 tests、100 tests 规格,目录价 ¥1,559 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
112007 | 25 tests | ¥1,559
112008 | 100 tests | ¥3,593
Product Details
Regulatory Status|RUO
Protein Concentration|Supplied at a lot-specific concentration.
Storage&Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use 5 µL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. PE has an excitation max at 565 nm and an emission max at 575 nm.
See All Formats|Clone 196AM2b
Background Information
CD196, also known as CCR6 (C-C chemokine receptor type 6), is a cell-surface chemokine receptor that plays an important role in immune cell trafficking and inflammatory responses. It belongs to the large family of G protein–coupled receptors (GPCRs) and is encoded by the CCR6 gene located on chromosome 6. The receptor is primarily expressed on several immune cell populations, including B lymphocytes, immature dendritic cells, and subsets of T cells such as memory T cells, Th17 cells, and regulatory T cells. Through its signaling functions, CD196 helps regulate immune cell migration and localization in tissues, particularly at mucosal and epithelial surfaces. :contentReference[oaicite:0]{index=0}
Structurally, CD196 is a membrane protein consisting of approximately 374 amino acids with a molecular weight of about 42 kDa. Like other GPCRs, it contains an extracellular N-terminal region, seven transmembrane α-helical domains, and a cytoplasmic C-terminal tail that interacts with intracellular signaling pathways. Activation of CD196 occurs when ligands bind to the extracellular portion of the receptor, triggering intracellular signaling cascades through associated G proteins and resulting in changes such as increased intracellular calcium levels and cell migration. :contentReference[oaicite:1]{index=1}
The principal ligand for CD196 is the chemokine CCL20, also known as macrophage inflammatory protein-3α (MIP-3α). The interaction between CCL20 and CD196 drives chemotaxis, guiding immune cells to specific tissues where immune responses are needed. In addition to CCL20, certain antimicrobial peptides from the β-defensin family can bind CD196 with lower affinity and trigger similar signaling effects. This receptor-ligand axis is particularly important in mucosal tissues such as the intestine and skin, where it helps recruit dendritic cells, B cells, and T cells to maintain immune surveillance and host defense. :contentReference[oaicite:2]{index=2}
CD196 has been implicated in several inflammatory and autoimmune diseases. For example, the CCL20–CCR6 signaling pathway contributes to the recruitment of Th17 cells, which produce the pro-inflammatory cytokine IL-17. Excessive accumulation of these cells is associated with diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Elevated CCR6 expression has also been observed in certain cancers and B-cell lymphomas, where it may influence tumor localization and immune interactions. :contentReference[oaicite:3]{index=3}
Because of its role in immune cell migration and inflammation, CD196 is considered a potential therapeutic target. Experimental strategies include small-molecule antagonists or antibodies that block CCR6 signaling to reduce inflammatory cell recruitment. Such approaches may help treat autoimmune disorders, chronic inflammatory diseases, and potentially certain cancers where the CCR6–CCL20 axis contributes to disease progression.
Data Sheets
Human peripheral blood lymphocytes were stained with iF647 anti-Human CD19 clone 019AB and PE anti-Human CD196 clone 196AM2b (left) or an isotype control (right).
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). PE Anti-Human CD196 (CCR6) Antibody(112007)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/pe-anti-human-cd196-ccr6-antibody.html.
TeleVM. (2026, November 12). PE Anti-Human CD196 (CCR6) Antibody(112007). 产品目录. https://www.suprotek.cn/products/item/pe-anti-human-cd196-ccr6-antibody.html
@misc{biocsp_item_pe_anti_human_cd196_ccr6_antibody,
title = {PE Anti-Human CD196 (CCR6) Antibody(112007)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/pe-anti-human-cd196-ccr6-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源